Biognosys Portfolio – Transformative Insights from Discovery to Clinic
This comprehensive brochure provides an overview of our services, software, and kits offering.
This comprehensive brochure provides an overview of our services, software, and kits offering.
The brochure provides you with an overview of the key features and benefits of our next-generation TrueDiscovery™ platform. In addition, it elaborates on our deep and reproducible proteome, phospho- and immune-proteome quantification and analysis. Finally, it digs into how we identify the most promising and actionable biomarkers for research and clinical decision-making.
Learn more about Biognosys’ proprietary TrueTarget™ platform in our latest brochure. This resource elaborates on how TrueTarget™ identifies the most promising and actionable drug targets to support your research.
The brochure provides an overview of the key features and benefits of our next-generation TrueSignature® platform. In addition, it elaborates on the specificities of our customizable panels for clinical and pharmacodynamics studies.
Biognosys AG
Wagistrasse 21
8952 Schlieren
Switzerland
Phone: +41 44 738 20 40
US Offices
Biognosys Inc
70 Bridge St, Suite 104
Newton, MA 02458
United States
